Neoadjuvant Chemotherapy for the Bulky-endophytic or Barrel-shaped Cervix.
- Author:
Jung Han LEE
;
Sam Hyun CHO
;
Seung Ryong KIM
;
Soo Hyun CHO
;
Hyang MOON
;
Jai Auk LEE
;
Youn Yeoung HWANG
;
Ki Young RYU
;
Kyung Tai KIM
;
Mee Sook KONG
;
Mun Hwl LEE
;
Jung Hye HWANG
- Publication Type:Original Article
- Keywords:
Barrel-shaped cervix;
Bulky-endophytic cervical carcinoma;
Neoadhuvant chemotherapy;
Concurrent chemo-radiotherapy
- MeSH:
Bleomycin;
Cervix Uteri*;
Cisplatin;
Disease-Free Survival;
Drug Therapy*;
Female;
Humans;
Hysterectomy;
Incidence;
Lymph Node Excision;
Neoplasm Metastasis;
Retrospective Studies;
Vinblastine
- From:Korean Journal of Gynecologic Oncology and Colposcopy
1999;10(2):164-172
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: This retrospective study was conducted to analyze the hypothesis that with neoadjuvant chemotherapy of vinblastine, bleomycin, and cisplatin followed by radical hysterectomy or radiation therapy and concurrent chemoradiation with cisplatin based regimen would improve survival in patients with barrel-shaped or bulky-endophytic (Diameter > 4cm) cervical carcinomas than those of radiation alone or combined radiation and surgery. STUDY DESIGN: Eighty-eight patients with barrel-shaped or bulky-endophytic cervical carcinomas, treated at the Hanyang University Hospital from 1983 to 1997, were the subjects of this investigation. Fifty-six of these patients were treated by neoadjuvant chemotherapy followed by radical hysterectomy with bilateral pelvic lymphadenectomy ( Stage I b2, 8; IIa, 15; IIb, 20; III- IV, 13), twelve patients were treated by neoadjuvant chemotherapy followed by radiation therapy ( Stage Ilb, 4; IIJ-IV, 8), and twenty patients were treated by concurrent chemo-radiotherapy ( Stage IIb, 2; III-IV, 18). RESULTS: The incidence of parametrial extension and pelvic lymphnode metastases was higher in patients with barrel-shaped or bulky-endophytic cervical carcinomas than non-barrel-shaped cervix (p .025: .001). 5-years disease free survival rate was determined for patients treated by neoadjuvant chemotherapy followed by radical hysterectomy with bilateral pelvic lymphadenectomy was 73.3 %. For patients treated by neoadjuvant chemotherapy followed by radiation therapy it was 45.7%. For patients treated by concurrent chemo-radiotherapy it was 46.1%. CONCLUSION: These data support an improvement in survival of patients with barrel-shaped or bulky-endophytic cervical carcinomas treated by neoadjuvant chemotherapy followed by radical hysterectomy or radiation therapy and concurrent chemo-radiotherapy.
